It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The US Will Fund Research to Make Pathogens Deadlier Again
The NIH lifted a 3-year funding moratorium on “gain-of-function” research meant to make deadly viruses stronger and more transmissible. www.vice.com...
An experiment that created a hybrid version of a bat coronavirus — one related to the virus that causes SARS (severe acute respiratory syndrome) — has triggered renewed debate over whether engineering lab variants of viruses with possible pandemic potential is worth the risks.
www.nature.com...
ARPA spent $10 million on one project in 2018 ‘to unravel the complex causes of bat-borne viruses that have recently made the jump to humans, causing concern among global health officials.” Another research project backed by both DARPA and NIH saw researchers at Colorado State University examine the coronavirus that causes Middle East Respiratory Syndrome (MERS) in bats and camels ‘to understand the role of these hosts in transmitting disease to humans.’
www.bozemandailychronicle.com... -53ff-87da-3d9c2466cd61.html
Researchers at Colorado State University examine the coronavirus that causes Middle East Respiratory Syndrome (MERS) in bats and camels ‘to understand the role of these hosts in transmitting disease to humans.
source.colostate.edu...
DARPA’s Preventing Emerging Pathogenic Threats, or PREEMPT program, which was officially announced in April 2018. PREEMPT focuses specifically on animal reservoirs of disease, specifically bats, and DARPA even noted in its press release in the program that it “is aware of biosafety and biosecurity sensitivities that could arise” due to the nature of the research. www.darpa.mil...
Department of Defense’s Cooperative Threat Reduction Program — began funding research involving bats and deadly pathogens, including the coronaviruses MERS and SARS, a year prior in 2017. www.grease-network.org...
US diplomats involved in trafficking of human blood and pathogens for secret military program dilyana.bg...
All research at a Fort Detrick laboratory that handles high-level disease-causing material, such as Ebola, is on hold indefinitely after the Centers for Disease Control and Prevention found the organization failed to meet biosafety standards. Also recently been involved in research borne out of the Pentagon’s recent concern about the use of bats as bioweapons. www.fredericknewspost.com... 6d.html
phys.org...
CDC Approves Partial Resumption of USAMRIID Fort Detrick Select Agent Research
globalbiodefense.com...
U.S. National Institute of Health collaborated with both the CIA and the Pentagon on infectious disease and bioweapons research
www.newsweek.com...
DARPA the top funder of the controversial ‘gene drive’ technology to permanently alter the genetics of entire populations while targeting others for extinction. www.rt.com...
www.theguardian.com...
The JASON group, composed of academic scientists, served as technical advisers to the U. S. government. Their study generated six broad classes of genetically engineered pathogens that could pose serious threats to society. These include but are not limited to binary biological weapons, designer genes, gene therapy as a weapon, stealth viruses, host-swapping diseases, and designer diseases
apps.dtic.mil...
Scientists fear US military plans to turn insects into vessels for genetically modified viruses could end badly
US military plan to spread viruses using insects could create ‘new class of biological weapon’, scientists warn
www.independent.co.uk...
Since 1969, USAMRIID has served as the Department of Defense's (DoD) lead laboratory for medical biological defense research. While our core mission is to protect the warfighter from biological threats, we also investigate disease outbreaks and threats to public health. Research conducted at USAMRIID leads to medical solutions—therapeutics, vaccines, diagnostics, and information—that benefit both military personnel and civilians. USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Development Command.
originally posted by: Ophiuchus 13
The US could of been researching a vaccine to fight a potential threat in the midst.
a reply to: FormOfTheLord
www.c4isrnet.com...
Since the early 2010s, DARPA has invested in a new type of vaccine technology — nucleic acid vaccines — which use the human body as its “bioreactor” to create the antibodies needed for immunity. DARPA funded this type of vaccine because traditional vaccine manufacturing is cumbersome, Jenkins said, and can take up to 18 months.
DARPA’s efforts on new mRNA vaccines have perhaps led to the best chance of effective immunization against COVID-19. This is in part thanks to a $25 million grant it awarded in 2013 to biotech company Moderna to manufacture mRNA vaccines to protect against a “wide range of known and unknown emerging infectious diseases and engineered biological threats."
In 2018, DARPA signed the first contracts for the Pandemic Prevention Platform (P3) program, a project that aims to create a “medical countermeasure” for a pandemic disease within 60 days of that pathogen’s identification using the mRNA vaccine technology. The platform relies on ongoing research into rapid antibody-discovery technology that must be linked with tech able to quickly manufacture those antibodies.